國立高雄大學圖資館 |

Language: English

Back

Coronary artery diseasetherapeutics ...

SpringerLink (Online service)

Coronary artery diseasetherapeutics and drug discovery /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Coronary artery diseaseedited by Miao Wang.
Reminder of title:	therapeutics and drug discovery /
other author:	Wang, Miao.
Published:	Singapore :Springer Singapore :2020.
Description:	ix, 339 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Coronary heart diseaseTreatment.
Online resource:	https://doi.org/10.1007/978-981-15-2517-9
ISBN:	9789811525179$q(electronic bk.)

Coronary artery diseasetherapeutics and drug discovery /
Coronary artery diseasetherapeutics and drug discovery /[electronic resource] :edited by Miao Wang. - Singapore :Springer Singapore :2020. - ix, 339 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.11770065-2598 ;. - Advances in experimental medicine and biology ;946..

Coronary Artery Disease: From Mechanism to Clinical Practice -- Evidence in guidelines for treatment of coronary artery disease -- Revascularization For Coronary Artery Disease: Principle And Challenges -- Antithrombotic drugs: pharmacology and perspectives -- Lipid modifying drugs: pharmacology and perspectives -- Anti-hypertensive drugs: pharmacology and perspectives -- Pharmaceutical treatment for Heart failure -- Drug discovery for coronary artery disease.

This book provides an overview of the etiology of coronary artery disease and focuses on the main therapies and drug interventions currently available. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease. The book is divided into eight chapters, the first of which describes the classical mechanism of coronary artery disease and its clinical presentations. Chapter 2 lists the principles of and related evidence on the prevention and treatment of coronary artery disease. This includes diet and lifestyle management, and guidelines for the treatment of acute coronary syndrome and stable coronary artery disease. In turn, Chapter 3 describes revascularization treatments, covering percutaneous coronary interventions, coronary artery bypass grafts and thrombolysis. This chapter also addresses the main therapeutic challenges. The following chapters provide an overview of three major categories of coronary artery disease drugs, which target thrombosis (Chapter 4), lipid metabolism (Chapter 5), and hypertension (Chapter 6) Heart failure constitutes the major health burden in the late stage of coronary artery disease; accordingly, current heart failure therapeutics and related drug pharmacology are described in Chapter 7. In closing, Chapter 8 provides a summary of on-going clinical trials for coronary artery disease drug development and discusses a number of promising areas in which intensive research into new therapeutics is being pursued. Given its scope, the book will be of interest to clinicians, medical students and research scientists, as well as to pharmaceutical professionals who are seeking new therapies and drugs for coronary artery disease and related disorders.

ISBN: 9789811525179$q(electronic bk.)

Standard No.: 10.1007/978-981-15-2517-9doiSubjects--Topical Terms:

357480
Coronary heart disease
--Treatment.

LC Class. No.: RC685.C6 / C676 2020

Dewey Class. No.: 616.12306

Coronary artery diseasetherapeutics and drug discovery /
LDR:03377nmm a2200337 a 4500 001 572352
003 DE-He213
005 20200727150042.0
006 m d
007 cr nn 008maaau
008 200925s2020 si s 0 eng d
020 $a 9789811525179$q(electronic bk.)
020 $a 9789811525162$q(paper)
024 7 $a 10.1007/978-981-15-2517-9 $2 doi
035 $a 978-981-15-2517-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC685.C6 $b C676 2020
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 616.12306 $2 23
090 $a RC685.C6 $b C822 2020
245 0 0 $a Coronary artery disease $h [electronic resource] : $b therapeutics and drug discovery / $c edited by Miao Wang.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a ix, 339 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1177
505 0 $a Coronary Artery Disease: From Mechanism to Clinical Practice -- Evidence in guidelines for treatment of coronary artery disease -- Revascularization For Coronary Artery Disease: Principle And Challenges -- Antithrombotic drugs: pharmacology and perspectives -- Lipid modifying drugs: pharmacology and perspectives -- Anti-hypertensive drugs: pharmacology and perspectives -- Pharmaceutical treatment for Heart failure -- Drug discovery for coronary artery disease.
520 $a This book provides an overview of the etiology of coronary artery disease and focuses on the main therapies and drug interventions currently available. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease. The book is divided into eight chapters, the first of which describes the classical mechanism of coronary artery disease and its clinical presentations. Chapter 2 lists the principles of and related evidence on the prevention and treatment of coronary artery disease. This includes diet and lifestyle management, and guidelines for the treatment of acute coronary syndrome and stable coronary artery disease. In turn, Chapter 3 describes revascularization treatments, covering percutaneous coronary interventions, coronary artery bypass grafts and thrombolysis. This chapter also addresses the main therapeutic challenges. The following chapters provide an overview of three major categories of coronary artery disease drugs, which target thrombosis (Chapter 4), lipid metabolism (Chapter 5), and hypertension (Chapter 6) Heart failure constitutes the major health burden in the late stage of coronary artery disease; accordingly, current heart failure therapeutics and related drug pharmacology are described in Chapter 7. In closing, Chapter 8 provides a summary of on-going clinical trials for coronary artery disease drug development and discusses a number of promising areas in which intensive research into new therapeutics is being pursued. Given its scope, the book will be of interest to clinicians, medical students and research scientists, as well as to pharmaceutical professionals who are seeking new therapies and drugs for coronary artery disease and related disorders.
650 0 $a Coronary heart disease $x Treatment. $3 357480
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Cardiology. $3 273804
650 2 4 $a Pharmacotherapy. $3 615025
650 2 4 $a Cardiac Surgery. $3 275925
700 1 $a Wang, Miao. $3 737796
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-981-15-2517-9
950 $a Biomedical and Life Sciences (Springer-11642)